Literature DB >> 15273265

Prevalence of problematic cocaine consumption in a city of southern Europe, using capture-recapture with a single list.

M T Brugal1, A Domingo-Salvany, E Díaz de Quijano, L Torralba.   

Abstract

This study aims to determine the magnitude and characteristics of problematic cocaine consumption in the city of Barcelona, Spain. Capture-recapture with a single source was used to estimate prevalence. Log-linear regression models with interaction terms were fitted to the total sample and to subgroups according to other drugs consumed. Emergency room indicator data were obtained from the Barcelona Drug Information System. Drug-related emergencies of Barcelona residents for 1999 were analyzed. During 1999, a total of 4,035 drug-related emergencies were seen in Barcelona hospitals. Of these, 1,656 (41%) involved cocaine consumption; 41% of these patients had consumed cocaine with an opiate; 29% used cocaine with other substances; and 30% used cocaine alone. It was estimated that there was a total of 25,988 problematic cocaine users (95% confidence interval 11,782-58,064), yielding a rate of 31.27 per 1,000 inhabitants aged 15 to 54 years (95% confidence interval 14.2-69.9). The number of cocaine-related emergencies was high enough to allow capture-recapture to be applied, thus obtaining an estimate of the prevalence of problematic cocaine consumption, and high enough to characterize users according to different profiles. The use of capture-recapture with a single source can be interesting for problems related to the urban context.

Entities:  

Mesh:

Year:  2004        PMID: 15273265      PMCID: PMC3455938          DOI: 10.1093/jurban/jth127

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  35 in total

1.  Cocaine-related symptoms in patients presenting to an urban emergency department.

Authors:  J A Rich; D E Singer
Journal:  Ann Emerg Med       Date:  1991-06       Impact factor: 5.721

Review 2.  Capture-recapture methods in epidemiology: methods and limitations.

Authors:  E B Hook; R R Regal
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

3.  Validity of methods for model selection, weighting for model uncertainty, and small sample adjustment in capture-recapture estimation.

Authors:  E B Hook; R R Regal
Journal:  Am J Epidemiol       Date:  1997-06-15       Impact factor: 4.897

4.  [Information on opiate and cocaine consumption in the emergency room clinical records: validity and reliability].

Authors:  K Pérez; A Domingo-Salvany; J M Garcés; R L Hartnoll
Journal:  Med Clin (Barc)       Date:  1996-11-23       Impact factor: 1.725

Review 5.  Capture-recapture and multiple-record systems estimation I: History and theoretical development. International Working Group for Disease Monitoring and Forecasting.

Authors: 
Journal:  Am J Epidemiol       Date:  1995-11-15       Impact factor: 4.897

6.  The epidemiology of cocaine use in Spain.

Authors:  G Barrio Anta; J Vicente Orta; M J Bravo Portela; L de la Fuente de Hoz
Journal:  Drug Alcohol Depend       Date:  1993-12       Impact factor: 4.492

Review 7.  Estimating the number of heroin users: a review of methods and empirical findings from The Netherlands.

Authors:  D J Korf; S A Reijneveld; J Toet
Journal:  Int J Addict       Date:  1994-09

8.  Cocaine use among heroin users in Spain: the diffusion of crack and cocaine smoking. Spanish Group for the Study on the Route of Administration of Drugs.

Authors:  G Barrio; L De la Fuente; L Royuela; A Díaz; F Rodríguez-Artalejo
Journal:  J Epidemiol Community Health       Date:  1998-03       Impact factor: 3.710

9.  Capture-recapture to estimate the size of the population with human immunodeficiency virus type 1 infection.

Authors:  D D Abeni; G Brancato; C A Perucci
Journal:  Epidemiology       Date:  1994-07       Impact factor: 4.822

10.  Use of capture-recapture to estimate the prevalence of opiate addiction in Barcelona, Spain, 1989.

Authors:  A Domingo-Salvany; R L Hartnoll; A Maguire; J M Suelves; J M Antó
Journal:  Am J Epidemiol       Date:  1995-03-15       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.